ARTICLE | Management Tracks
iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more
June 10, 2020 1:42 AM UTC
iTeos Therapeutics S.A. made several hires Tuesday, including Matthew Gall as CFO and Yvonne McGrath as VP of R&D. Gall was SVP of corporate development at Sarepta Therapeutics Inc. (NASDAQ:SRPT); McGrath was CSO of Complix N.V. The immuno-oncology company also hired Philippe Brantegem as VP, human resources. iTeos, which is developing an ADORA2A antagonist and an anti-TIGIT mAb, raised $125 million in a series B2 in April (see “iTeos in Private Round with Crossovers”).
Jeffrey Humphrey will succeed Adrian Senderowicz as CMO at Constellation Pharmaceuticals Inc. (NASDAQ:CNST), effective June 22. Before joining the cancer epigenetics company, Humphrey was chief development officer of Kyowa Kirin Co. Ltd. (Tokyo:4151)...